Gene therapy for radiation dry mouth tracked long-term
NCT ID NCT06544798
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows adults who previously received a gene therapy (AAV2-hAQP1) for dry mouth caused by radiation treatment for head and neck cancers. Researchers will check for side effects and how well the therapy works over time. About 276 people who already got the therapy in an earlier study will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRADE 2 AND 3 LATE XEROSTOMIA CAUSED BY RADIOTHERAPY FOR CANCERS OF THE UPPER AERODIGESTIVE TRACT, EXCLUDING THE PAROTID GLANDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alleghany General Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
Atrium Health
Charlotte, North Carolina, 28209, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Erie County Medical Center
Buffalo, New York, 14215, United States
-
Miami Cancer Institute at Baptist Health South Florida
Miami, Florida, 33176, United States
-
Shirley and Jim Fielding Northeast Cancer Centre - Health Sciences North
Greater Sudbury, Ontario, P3E 5J1, Canada
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Missouri
Columbia, Missouri, 65212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.